I now have comprehensive content from Ruppel's Manual. Here is the complete 15-mark MD exam answer on DLCO:
DLCO (Diffusing Capacity of the Lung for Carbon Monoxide) — Complete Answer for MD Examination (15 Marks)
1. DEFINITION AND BASIC CONCEPT
DLCO (also called transfer factor, TLCO) measures the transfer of a diffusion-limited gas (carbon monoxide) across the alveolocapillary membranes. It is reported in mL CO/min/mmHg at STPD conditions (standard temperature, pressure, dry), or in SI units as mmol/min/kPa (conversion: multiply SI by 2.986 to get mmHg units).
Normal average resting DLCO ≈ 25 mL CO/min/mmHg (significant individual variability).
2. PHYSIOLOGICAL BASIS
CO combines with hemoglobin approximately 210 times more readily than O₂. In the presence of normal Hb and ventilatory function, the primary limiting factor to CO diffusion is the alveolocapillary membrane.
Diffusion conductance has two components in series:
$$\frac{1}{D_{LCO}} = \frac{1}{D_m} + \frac{1}{\theta V_C}$$
| Component | Meaning |
|---|
| 1/Dm | Membrane resistance (alveolocapillary membrane conductance) |
| 1/θVc | Red blood cell membrane resistance + rate of CO–Hb reaction |
| θ | Transfer rate of CO per mL capillary blood |
| Vc | Pulmonary capillary blood volume |
In healthy patients, each factor contributes approximately half the total resistance to gas exchange.
Basic equation:
$$D_{LCO} = \frac{\dot{V}{CO}}{P{ACO} - P_{CCO}}$$
(P_CCO assumed = 0, since no CO is normally in pulmonary capillary blood)
3. METHODS OF MEASUREMENT
A. Single-Breath (Breath-Hold) Method — Dlcosb (Modified Krogh's Technique) ⭐ Most Used
Procedure:
- Patient exhales completely to RV
- Rapidly inspires a full VC breath of test gas mixture (0.3% CO + tracer gas [He/CH₄/Ne] + 21% O₂ + balance N₂)
- Holds breath at TLC for ~10 seconds
- Exhales — dead space gas (750–1000 mL) discarded, then alveolar sample collected and analyzed
Calculation (Jones and Meade method):
$$D_{LCO_{sb}} = \frac{V_A \times 60}{(P_B - 47) \times T} \times \ln\frac{F_{ACO_0}}{F_{ACO_T}}$$
Where:
- VA = alveolar volume (mL, STPD)
- PB = barometric pressure
- T = breath-hold time (seconds)
- FAco₀ = fraction of CO in alveolar gas at start of breath hold
- FAcoT = fraction of CO in alveolar gas at end of breath hold
Alveolar Volume (VA) Calculation:
$$V_A = (V_I - V_D) \times \frac{F_{I_{tracer}}}{F_{A_{tracer}}} \times \text{STPD correction}$$
Kco (Krogh constant):
$$K_{CO} = \frac{D_{LCO}}{V_A}$$
Normal: ~4–5 mL CO/min/mmHg/L lung volume. ATS-ERS recommends reporting Kco (not DL/VA) to avoid physiological misinterpretation.
B. Rebreathing Method (Dlcorb)
Patient rebreathes from a reservoir (0.3% CO + tracer + air) for 30–60 sec at ~30 breaths/min. Less sensitive to V/Q abnormalities; useful during exercise; complex calculations required.
C. Intrabreath Method (Dlcoib)
Slow controlled exhalation (~0.5 L/sec) from TLC to RV after inspiring test gas. Does not require breath hold; useful for patients who cannot hold breath; allows multiple Dlco values plotted against lung volume.
D. Membrane Diffusing Capacity (1/Dm + 1/θVc)
Two Dlcosb tests performed at different alveolar PO₂ levels (air, then O₂). Used to separate membrane resistance from RBC/Hb reaction resistance. Research application primarily.
E. Nitric Oxide (Dlno)
NO uptake limited almost entirely by pulmonary capillary membranes (θNO is very large), so Dlno measures membrane resistance directly. Measured via chemiluminescence analyzer.
4. CRITERIA FOR ACCEPTABILITY (ATS-ERS)
| Criterion | Requirement |
|---|
| Inspiration | From RV to TLC in < 4 seconds |
| Inspired volume | ≥ 90% of largest VC (Grade A) or ≥ 85% + VA within 200 mL/5% (Grade B) |
| Breath-hold time | 8–12 seconds (Jones & Meade method) |
| Exhalation | Total exhale ≤ 4 seconds |
| Number of tests | Average ≥ 2 acceptable tests; ≤ 5 maneuvers total |
| Inter-test repeatability | Duplicate determinations within 2 mL/min/mmHg (0.67 mmol/min/kPa) |
| Between maneuvers | ≥ 4-minute wait (COHb washout) |
| VA vs TLC | VA must never exceed TLC by any method |
| Posture | Patient seated; no exertion immediately before test |
Quality Grading (Dlco Grading System):
| Grade | IVC/VC | BHT (sec) | Sample collection |
|---|
| A | >90% | 8–12 | <4 sec |
| B | >85% | 8–12 | <4 sec |
| C | >80% | 8–12 | <5 sec |
| D | <80% | <8 or >12 | <5 sec |
| F | <80% | <8 or >12 | >5 sec |
5. CORRECTIONS TO PREDICTED VALUES
A. Hemoglobin Correction
DLCO is directly proportional to Hb. Corrections are applied to the predicted (not measured) value:
-
Males (standard Hb = 14.6 g/dL):
$$DLCO_{pred(Hb)} = DLCO_{pred} \times \frac{1.7 \times Hb}{10.22 + Hb}$$
-
Females / children <15 yr (standard Hb = 13.4 g/dL):
$$DLCO_{pred(Hb)} = DLCO_{pred} \times \frac{1.7 \times Hb}{9.38 + Hb}$$
Rule of thumb: CO uptake varies ~7% per gram of Hb.
B. Carboxyhemoglobin (COHb) Correction
$$DLCO_{pred(COHb)} = DLCO_{pred} \times (1 - COHb%)$$
Each 1% increase in COHb → ~1% decrease in measured DLCO. Patients asked to refrain from smoking 24 hours before test.
C. Altitude Correction
DLCO increases ~0.35% per mmHg decrease in PaO₂ (0.31%/mmHg decrease in PiO₂). Formula:
$$DLCO_{pred,altitude} = \frac{DLCO_{pred}}{1.0 + 0.0031 \times (P_{AO_2} - 100)}$$
D. Lung Volume (VA) Correction
When subject inspires less than full VC:
$$DLCO_{(at\ V_{Am})} = DLCO_{(at\ V_{Ap})} \times \left(0.58 + 0.42 \times \frac{V_{Am}}{V_{Ap}}\right)$$
6. PHYSIOLOGICAL FACTORS AFFECTING DLCO
| Factor | Effect on DLCO |
|---|
| ↓ Hb / anemia | Decreases |
| ↑ Hb / polycythemia | Increases |
| ↑ COHb (smoking) | Decreases (CO back-pressure effect) |
| ↑ Pulmonary capillary blood volume (exercise, supine, L→R shunt, hemorrhage) | Increases |
| Valsalva maneuver (↑ intrathoracic pressure) | Decreases (↓ capillary blood volume) |
| Müller maneuver (↓ intrathoracic pressure) | Increases (↑ capillary blood volume) |
| Altitude (↓ PaO₂) | Increases |
| Exercise | Increases (2–3× normal) |
| Supine position | Increases |
| Asthma / obesity (some patients) | Increases |
| ↑ Alveolar PCO₂ (hypoventilation) | Increases (↓ PAO₂ → less O₂-CO competition) |
7. SIGNIFICANCE AND PATHOPHYSIOLOGY
Causes of DECREASED DLCO:
A. Parenchymal / Interstitial Lung Diseases (Diffusion Defect)
- Idiopathic pulmonary fibrosis, sarcoidosis, asbestosis, berylliosis, silicosis, SLE, scleroderma
- Alveolitis from toxic gas or organic agent inhalation
- Mechanism: ↓ surface area + ↓ capillary bed + membrane thickening → ↓ diffusion
B. Emphysema (COPD)
- ↓ Alveolar surface area (alveolar wall destruction)
- ↓ Associated capillary beds
- ↑ Distance from terminal bronchiole to alveolocapillary membrane
- V/Q mismatch (airway collapse → gas trapping)
- Kco is typically reduced (V/Q mismatch component)
C. Pulmonary Vascular Disease
- Pulmonary hypertension, pulmonary vasculitis, pulmonary emboli
- Reduced capillary bed → ↓ Vc → ↓ DLCO
- Often presents as reduced DLCO with otherwise normal spirometry
D. Anemia — ↓ Hb available for CO binding
E. COHb elevation — ↓ diffusion gradient
F. Pulmonary Edema / CHF — disruption of alveolar ventilation, volume loss, congestion
G. Lung Resection / Pneumonectomy — ↓ surface area proportional to volume removed
H. Radiation pneumonitis / fibrosis — membrane damage
I. Drug toxicity — bleomycin, amiodarone, anti-rejection drugs
J. Hepatopulmonary syndrome — vascular + gas exchange defect
Exception: Lung volume reduction surgery (LVRS) and bullectomy may improve DLCO by improving V/Q matching in remaining lung.
Causes of INCREASED DLCO:
- Pulmonary hemorrhage (extra Hb in alveolar space)
- Polycythemia
- Left-to-right shunts (↑ pulmonary blood volume)
- Obesity (some patients; mechanism unclear — possibly ↑ capillary blood volume)
- Exercise (2–3×)
- Asthma (some patients — cause unclear)
- Early/compensated CHF (vascular engorgement can transiently ↑ DLCO before decompensation)
8. INTERPRETIVE STRATEGY (ATS-ERS Framework)
- Were maneuvers acceptable and repeatable? (within 2 mL/min/mmHg)
- Were appropriate corrections applied? (Hb, COHb, altitude, VA)
- Are reference values appropriate? (ATS-ERS recommend GLI — Global Lung Initiative equations)
- Is DLCO < LLN? → Gas exchange abnormality likely
- Is Kco within normal limits? → Reduced DLCO likely from parenchymal change, vascular disease, or pulmonary hypertension (consider clinical correlation)
- Is Kco also reduced? → V/Q mismatch (obstruction, dead space); compare VA to TLC — large difference → uneven ventilation
- Is DLCO increased after corrections? → ↑ pulmonary blood volume, hemorrhage, obesity, L→R shunt, undiagnosed asthma
- Is DLCO < 60% predicted? → Consider arterial blood gases and exercise O₂ desaturation study
Interpreting DLCO and Kco Together:
| Pattern | DLCO | Kco | Likely Cause |
|---|
| Both reduced | ↓ | ↓ | Obstruction (V/Q mismatch), emphysema |
| DLCO reduced, Kco normal/near-normal | ↓ | N | Restriction (↓ VA proportionately), vascular disease, pulmonary hypertension |
| DLCO increased | ↑ | ↑ | Hemorrhage, polycythemia, exercise, L→R shunt |
| Post-pneumonectomy | ↓ | ↑ | ↓ Volume, preserved gas exchange units |
9. CLINICAL APPLICATIONS
| Application | Role of DLCO |
|---|
| Distinguish emphysema from chronic bronchitis/asthma | ↓↓ DLCO in emphysema; may be normal/near-normal in bronchitis |
| Predict exercise-induced O₂ desaturation | DLCO < 60% predicted → 75% sensitivity and specificity for desaturation |
| Monitor drug toxicity (amiodarone, bleomycin) | Serial DLCO — falling values indicate lung damage |
| Preoperative lung resection assessment | DLCO predicts postoperative reserve |
| Assess response to LVRS / bullectomy | DLCO may improve despite reduced volume |
| Evaluate hepatopulmonary syndrome | DLCO reflects vascular + membrane component |
| Interstitial lung disease staging and follow-up | Sensitive marker of progression |
10. EQUIPMENT REQUIREMENTS (ATS-ERS Standards)
- Volume accuracy: ±2.5% over 8-L range (daily syringe check)
- Analyzer linearity: 0–full span ±0.5%, checked quarterly
- Circuit resistance: < 1.5 cm H₂O/L/sec at 6 L/sec
- Dead space: < 200 mL (instrument + anatomic)
- Timing: accurate to ±1% over 10 seconds
- Anatomic dead space estimated as 2.2 mL/kg ideal body weight
- Gas volumes corrected from ATPS → STPD for DLCO calculation; VA expressed in BTPS
- Biological controls tested weekly
SUMMARY TABLE
| Parameter | Normal Value |
|---|
| DLCO (resting adult) | ~25 mL CO/min/mmHg |
| Kco | ~4–5 mL CO/min/mmHg/L |
| Breath-hold time | 10 seconds (range 8–12) |
| LLN for clinical interpretation | <80% predicted (or statistical LLN) |
| Significant reduction | <60% predicted → exercise O₂ testing |
| Inter-test reproducibility | Within 2 mL/min/mmHg |
Source: Ruppel's Manual of Pulmonary Function Testing, 12th Edition, Chapter 3 (pp. 84–108) — Diffusing Capacity Tests. Reference equations per ATS-ERS 2017 standardization guidelines; GLI reference set recommended.
